We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Treatment for Clostridium difficile Infection in Adults—Reply

Krishna Rao, MD1; Natasha Bagdasarian, MD, MPH2; Preeti N. Malani, MD, MSJ1,3
[+] Author Affiliations
1Department of Internal Medicine, University of Michigan Health System, Ann Arbor
2Department of Internal Medicine, Wayne State University, Detroit, Michigan
3Associate Editor, JAMA
JAMA. 2015;313(19):1976. doi:10.1001/jama.2015.3674.
Text Size: A A A
Published online


In Reply We agree with Drs McDonald and Lee that PPI use has been associated with incident and recurrent C difficile infection. Even though we mentioned this association in the text, tables, and figures of our review, we chose not to include PPI or other modifiable risk factors (other than concurrent use of non–C difficile infection antibiotics), in the treatment algorithm. There are numerous reports highlighting an association with acquisition and recurrence of C difficile infection; however, to date, no one has prospectively studied whether discontinuation of PPI therapy improves outcomes from C difficile infection. Despite this, we believe discontinuation of PPI therapy is a reasonable consideration, particularly because many patients receive it unnecessarily.1


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




May 19, 2015
Emily G. McDonald, MD; Todd C. Lee, MD, MPH
1Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
JAMA. 2015;313(19):1974-1975. doi:10.1001/jama.2015.3668.
May 19, 2015
Cong Dai, MD, PhD; Min Jiang, MD, PhD; Ming-Jun Sun, MD, PhD
1Department of Gastroenterology, First Affiliated Hospital of China Medical University, Shenyang City, Liaoning Province, China
JAMA. 2015;313(19):1975-1976. doi:10.1001/jama.2015.3671.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...